1. Home
  2. KALV vs BRBS Comparison

KALV vs BRBS Comparison

Compare KALV & BRBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • BRBS
  • Stock Information
  • Founded
  • KALV N/A
  • BRBS 1893
  • Country
  • KALV United States
  • BRBS United States
  • Employees
  • KALV N/A
  • BRBS N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • BRBS Commercial Banks
  • Sector
  • KALV Health Care
  • BRBS Finance
  • Exchange
  • KALV Nasdaq
  • BRBS Nasdaq
  • Market Cap
  • KALV 362.2M
  • BRBS 299.1M
  • IPO Year
  • KALV N/A
  • BRBS N/A
  • Fundamental
  • Price
  • KALV $10.03
  • BRBS $3.58
  • Analyst Decision
  • KALV Strong Buy
  • BRBS
  • Analyst Count
  • KALV 8
  • BRBS 0
  • Target Price
  • KALV $25.67
  • BRBS N/A
  • AVG Volume (30 Days)
  • KALV 321.8K
  • BRBS 160.8K
  • Earning Date
  • KALV 03-10-2025
  • BRBS 01-30-2025
  • Dividend Yield
  • KALV N/A
  • BRBS N/A
  • EPS Growth
  • KALV N/A
  • BRBS N/A
  • EPS
  • KALV N/A
  • BRBS N/A
  • Revenue
  • KALV N/A
  • BRBS $97,334,000.00
  • Revenue This Year
  • KALV N/A
  • BRBS N/A
  • Revenue Next Year
  • KALV N/A
  • BRBS N/A
  • P/E Ratio
  • KALV N/A
  • BRBS N/A
  • Revenue Growth
  • KALV N/A
  • BRBS N/A
  • 52 Week Low
  • KALV $7.30
  • BRBS $2.33
  • 52 Week High
  • KALV $15.50
  • BRBS $3.83
  • Technical
  • Relative Strength Index (RSI)
  • KALV 59.09
  • BRBS 54.71
  • Support Level
  • KALV $8.99
  • BRBS $3.44
  • Resistance Level
  • KALV $11.00
  • BRBS $3.75
  • Average True Range (ATR)
  • KALV 0.57
  • BRBS 0.14
  • MACD
  • KALV 0.11
  • BRBS 0.00
  • Stochastic Oscillator
  • KALV 57.08
  • BRBS 55.26

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About BRBS Blue Ridge Bankshares Inc.

Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance, credit cards, online banking, telephone banking, mobile banking, and other activities to other businesses, professionals, consumers, nonprofits, and municipalities. Its primary source of revenue is interest income from the lending activities.

Share on Social Networks: